Multicenter Retrospective Study of Xenotransfusion of Canine Plasma Products to Cats: 14 Cases (2022-2024).

April 30, 2026

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to evaluate the indications, protocols, and outcomes of canine plasma transfusions in cats.
Retrospective descriptive study conducted across multiple centers from 2022 to 2024.
Included 14 client-owned cats that received canine plasma products with transfusion records available.
Measured parameters included coagulopathy diagnosis, transfusion reactions, and outcomes.
14 cats received 16 transfusions, with coagulopathy confirmed in 7 and oncotic support needed in 5.
3 cats normalized both PT and aPTT after transfusion; 2 experienced acute respiratory distress signs.
5 cats survived to discharge; 6 were euthanized, and 3 experienced cardiopulmonary arrest.

We only have this paper's title and publication details.

Retrospective study examines outcomes of canine plasma transfusions in cats, revealing potential benefits and safety concerns.

No takes yet. Share an insight, caveat, or question.

Gómez‐Soto et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share